Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study
Abstract Background Several studies have shown that heart rate control with selective beta-1 blockers in septic shock is safe. In these trials, esmolol was administered 24 h after onset of septic shock in patients who remained tachycardic. While an earlier use of beta-blockers might be beneficial, s...
Main Authors: | Bruno Levy, Caroline Fritz, Caroline Piona, Kevin Duarte, Andrea Morelli, Philippe Guerci, Antoine Kimmoun, Nicolas Girerd |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Critical Care |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13054-020-03445-w |
Similar Items
-
January 2014 Tucson critical care journal club: esmolol in septic shock
by: Strawter C, et al.
Published: (2014-02-01) -
Vasopressin and septic shock
by: Sarah Mousavi
Published: (2015-10-01) -
Norepinephrine was superior in death risk reducing and hemodynamics compared to dopamine in treatment of patients with septic shock
by: Lu Xudong, et al.
Published: (2021-02-01) -
Effect of norepinephrine dosage on mortality in patients with septic shock
by: Hitoshi Yamamura, et al.
Published: (2018-02-01) -
Norepinephrine Infusion in the Emergency Department in Septic Shock Patients: A Retrospective 2-Years Safety Report and Outcome Analysis
by: Antonio Messina, et al.
Published: (2021-01-01)